Journal article
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group
The Lancet (British edition), Vol.348(9041), pp.1535-1541
12/07/1996
DOI: 10.1016/s0140-6736(96)07088-2
PMID: 8950879
Abstract
Previous studies have shown that alendronate can increase bone mineral density (BMD) and prevent radiographically defined (morphometric) vertebral fractures. The Fracture Intervention Trial aimed to investigate the effect of alendronate on the risk of morphometric as well as clinically evident fractures in postmenopausal women with low bone mass.
Details
- Title: Subtitle
- Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group
- Creators
- Dennis M Black - Department of Epidemiology and Biostatistics, University of California, San Francisco 94143, USASteven R CummingsDavid B KarpfJane A CauleyDesmond E ThompsonMichael C NevittDouglas C BauerHarry K GenantWilliam L HaskellRobert MarcusSusan M OttJames C TornerSara A QuandtTheodore F ReissKristine E Ensrud
- Resource Type
- Journal article
- Publication Details
- The Lancet (British edition), Vol.348(9041), pp.1535-1541
- DOI
- 10.1016/s0140-6736(96)07088-2
- PMID
- 8950879
- NLM abbreviation
- Lancet
- ISSN
- 0140-6736
- eISSN
- 1474-547X
- Publisher
- England
- Language
- English
- Date published
- 12/07/1996
- Academic Unit
- Epidemiology; Surgery; Injury Prevention Research Center; Neurosurgery
- Record Identifier
- 9983996071202771
Metrics
23 Record Views